المؤلفون: Xu Tong, Tao Zhan, Xiaoqin Dong, Dong Xu

المصدر: Frontiers in Immunology; 2024, p1-13, 13p

مصطلحات موضوعية: IMMUNE checkpoint inhibitors, DRUG side effects, FEVER, IPILIMUMAB, THERAPEUTICS, IMMUNE system

المؤلفون: Yakobson, Alexander, Rouvinov, Keren, Cohen, Aharon Y., Goldstein, Iris, Abu Saleh, Omar, Solomon, Adam, Dudnik, Yulia, Shalata, Walid

المصدر: Journal of Personalized Medicine; Sep2023, Vol. 13 Issue 9, p1340, 16p

مصطلحات موضوعية: IMMUNE checkpoint inhibitors, DRUG side effects, THERAPEUTICS, IPILIMUMAB, RENAL cell carcinoma, NON-small-cell lung carcinoma, INTRAVENOUS immunoglobulins, CARPAL tunnel syndrome

المؤلفون: Curkovic, Nina B., Johnson, Douglas B.

المصدر: Expert Review of Clinical Immunology; 2023, Vol. 19 Issue 9, p1117-1129, 13p

مصطلحات موضوعية: IMMUNE checkpoint inhibitors, DRUG side effects, THERAPEUTICS, IPILIMUMAB, IMMUNE checkpoint proteins

المؤلفون: Xinyu Guo, Shi Chen, Xueyan Wang, Xiaowei Liu

المصدر: Frontiers in Immunology; 4/4/2023, Vol. 14, p01-10, 10p

مصطلحات موضوعية: NON-small-cell lung carcinoma, IPILIMUMAB, DRUG side effects, CANCER diagnosis, IMMUNE checkpoint inhibitors, THERAPEUTICS

المؤلفون: Teufel, Andreas¹ (AUTHOR) andreas.teufel@medma.uni-heidelberg.de, Zhan, Tianzuo¹ (AUTHOR), Härtel, Nicolai¹ (AUTHOR), Bornschein, Jan² (AUTHOR), Ebert, Matthias P.¹ (AUTHOR), Schulte, Nadine¹ (AUTHOR)

المصدر: Cancer Letters. Aug2019, Vol. 456, p80-87. 8p.

مصطلحات موضوعية: *IPILIMUMAB, *DRUG side effects, *ADVERSE health care events, *ENDOCRINE glands, *PROTEIN-tyrosine kinases, *THERAPEUTICS

المؤلفون: Kreft, Sophia¹ (AUTHOR), Gesierich, Anja¹ (AUTHOR), Eigentler, Thomas² (AUTHOR), Franklin, Cindy³ (AUTHOR), Valpione, Sara⁴ (AUTHOR), Ugurel, Selma^5,6 (AUTHOR), Utikal, Jochen^7,8 (AUTHOR), Haferkamp, Sebastian⁹ (AUTHOR), Blank, Christian¹⁰ (AUTHOR), Larkin, James¹¹ (AUTHOR), Garbe, Claus² (AUTHOR), Schadendorf, Dirk^5,6 (AUTHOR), Lorigan, Paul⁴ (AUTHOR), Schilling, Bastian¹ (AUTHOR) schilling_b@ukw.de

المصدر: European Journal of Cancer. Jul2019, Vol. 116, p207-215. 9p.

مصطلحات موضوعية: *MELANOMA prognosis, *IPILIMUMAB, *PROTEIN kinase inhibitors, *BLOOD cell count, *ADJUVANT treatment of cancer, *COMBINATION drug therapy, *CONFIDENCE intervals, *DRUG delivery systems, *DRUG side effects, *IMMUNOTHERAPY, *MEDICAL referrals, *MELANOMA, *METASTASIS, *SURVIVAL, *TUMOR classification, *TREATMENT effectiveness, *RETROSPECTIVE studies, *DISEASE progression, *TERTIARY care, *CHEMORADIOTHERAPY, *THERAPEUTICS

المؤلفون: Yang, Annie¹, Baxi, Shrujal¹, Korenstein, Deborah¹ korenstd@mskcc.org

المصدر: Journal of Oncology Practice. Feb2018, Vol. 14 Issue 2, p72-76. 6p.

مصطلحات موضوعية: *THERAPEUTIC use of monoclonal antibodies, *IPILIMUMAB, *CANCER chemotherapy, *COLITIS, *DRUG side effects, *DRUG toxicity, *HEPATITIS, *MONOCLONAL antibodies, *PATIENT safety, *SERIAL publications, *SKIN inflammation, *THYROIDITIS, *TUMORS, *CLINICAL trial registries, *TREATMENT effectiveness, *INVESTIGATIONAL drugs, *THERAPEUTICS

الشركة/الكيان: UNITED States. Food & Drug Administration

المؤلفون: Akel, Reem¹, Anouti, Bilal¹, Tfayli, Arafat¹ at35@aub.edu.lb

المصدر: Case Reports in Oncology. May-Aug2017, Vol. 10 Issue 2, p456-461. 6p.

مصطلحات موضوعية: *DRUG side effects, *IPILIMUMAB, *THERAPEUTICS

المؤلفون: L Hefler, Jade, M Bailey, Lauren, El Rahi, Cynthia, C Schefler, Amy, Bernicker, Eric H

المصدر: Journal of Oncology Pharmacy Practice; Jul2021, Vol. 27 Issue 5, p1261-1264, 4p

مصطلحات موضوعية: INFLAMMATION prevention, COMBINATION drug therapy, IMMUNE checkpoint inhibitors, SMALL cell carcinoma, DEXAMETHASONE, OCULAR manifestations of general diseases, LUNG tumors, IPILIMUMAB, INTRAOCULAR drug administration, CONTROLLED release drugs, UVEAL diseases, DRUG side effects, IMMUNOTHERAPY, THERAPEUTICS

المؤلفون: Lee, B.^1,2,3, Wong, A.¹, Kee, D.¹, Neeson, P.^4,5, Shackleton, M.^1,5,6, McArthur, G.^1,3,5,7,8, Sandhu, S.^1,3,8 shahneen.sandhu@petermac.org

المصدر: Annals of Oncology. Jun2016, Vol. 27 Issue 6, p1174-1177. 4p. 1 Color Photograph, 1 Chart.

مصطلحات موضوعية: *RHEUMATOID arthritis treatment, *IPILIMUMAB, *METASTASIS, *DRUG side effects, *GENETIC polymorphisms, *THERAPEUTICS